SEQLL INC. FIRST AMENDMENT TO SERIES A-2 PREFERRED STOCK PURCHASE AGREEMENTPreferred Stock Purchase Agreement • April 23rd, 2019 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
This First Amendment to Series A-2 Preferred Stock Purchase Agreement (this “Amendment”) is dated as of January 12, 2018, and is made by and among SeqLL Inc., a Delaware corporation (the “Company”), and certain purchasers of shares of Series A-2 Preferred Stock of the Company (the “Purchasers”) pursuant to that certain Series A-2 Preferred Stock Purchase Agreement, dated February 19, 2016, by and among the Company and the Purchasers (as amended to date, the “Agreement”). Capitalized terms not otherwise defined herein shall have the meaning given them in the Agreement.
AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENTSale Agreement • April 23rd, 2019 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
SEQLL INC. SERIES A-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTStock Purchase Agreement • April 23rd, 2019 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
THIS SERIES A-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”), is made as of the 30th day of May, 2014 by and among SeqLL Inc., a Delaware corporation (the “Company”), the investors listed on Exhibit A attached to this Agreement (each a “Purchaser” and together the “Purchasers”).
SEQLL INC. SERIES A-2 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTPreferred Stock Purchase Agreement • April 23rd, 2019 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
exchange agreementExchange Agreement • April 23rd, 2019 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
This Exchange Agreement (this “Agreement”) is entered effective as of the 30th day of September, 2018 (the “Exchange Date”), by and between SEQLL INC., a Delaware Corporation (the “Company”) and ST. LAURENT INVESTMENTS, LLC (the “Exchanging Holder”).
SEQLL, Inc. Stock Option AwardStock Option Award Agreement • April 23rd, 2019 • SeqLL, Inc. • Laboratory analytical instruments
You have been granted an option (an “Option”) to purchase shares of common stock of SeqLL, Inc., a Delaware corporation (the “Company”), which is subject to the terms of the SeqLL, Inc. 2014 Equity Incentive Plan (the “Plan”) and this Stock Option Award Agreement (this “Agreement”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Plan.
SUB-LICENSE AGREEMENTSub-License Agreement • April 23rd, 2019 • SeqLL, Inc. • Laboratory analytical instruments
HELICOS is debtor in possession in the case under Chapter 11 of the United States Bankruptcy Code entitled In re Helicos Biosciences Corporation, Case No. 12-19091 — FJB (the “Chapter 11 Case”), pending in the United States Bankruptcy Court for the District of Massachusetts, Eastern Division (the “Court”).
ContractSeqLL, Inc. • April 23rd, 2019 • Laboratory analytical instruments • Delaware
THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED.
